Tetra Radar · FDA Approvals · Decision date

LEQEMBI: FDA decision date

Biogen Inc. (BIIB) · 24 May 2026

In January 2026 the FDA accepted for review the supplemental BLA for LEQEMBI subcutaneous autoinjector, LEQEMBI IQLIK, for a weekly starting dose, with a PDUFA action date of May 24, 2026.

Source: 10-Q of 29 April 2026

The date has passed; Tetra Radar has not recorded an approval.

A PDUFA date is the date by which the FDA has said it will decide on an application. Dates can move, and a decision is not an approval. Tetra Radar observes public information for research purposes. It does not provide investment advice.

Get the Dispatch free.